Jubilant Life Sciences’ arm to launch offering of bonds outside India

25 Feb 2019 Evaluate

Jubilant Life Sciences’ wholly-owned subsidiary -- Jubilant Pharma (JPL) has received approval to launch an offering of unsecured bonds outside India. The Notes are proposed to be issued to institutional investors outside India and listed and quoted on the Official List of the Singapore Exchange Securities Trading.

JPL proposes to undertake meetings with one or more potential international institutional investors located in different jurisdictions. The Board of Directors of Jubilant Pharma at its meeting held on February 25, 2019 has approved the same.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.

Jubilant Pharmova Share Price

1076.40 7.20 (0.67%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×